# Open Label Pilot Study of Apremilast in Treatment of Rosacea

> **NCT01045551** · PHASE2 · COMPLETED · sponsor: **Julian M. Mackay-Wiggan** · enrollment: 10 (actual)

## Conditions studied

- Erythematotelangiectatic Rosacea
- Papulopustular Rosacea

## Interventions

- **DRUG:** Apremilast

## Key facts

- **NCT ID:** NCT01045551
- **Lead sponsor:** Julian M. Mackay-Wiggan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2013-01
- **Final completion:** 2014-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2016-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01045551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01045551, "Open Label Pilot Study of Apremilast in Treatment of Rosacea". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01045551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*